Taslimi Shervin, Modabbernia Amirhossein, Amin-Hanjani Sepideh, Barker Fred G, Macdonald R Loch
From the Division of Neurosurgery (S.T.), University of Toronto, Canada; Department of Psychiatry (A.M.), Icahn School of Medicine, Mount Sinai Hospital, New York, NY; Department of Neurosurgery (S.A.-H.), University of Illinois at Chicago; Neurosurgical Service (F.G.B.), Massachusetts General Hospital, Harvard Medical School, Boston; Division of Neurosurgery (R.L.M.), St. Michael's Hospital, Labatt Family Centre of Excellence in Brain Injury and Trauma Research, Keenan Research Centre for Biomedical Science; and the Department of Surgery (R.L.M.), Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Canada.
Neurology. 2016 May 24;86(21):1984-91. doi: 10.1212/WNL.0000000000002701. Epub 2016 Apr 22.
We pooled the results of studies on natural history of cavernous malformations (CM) to calculate point estimates and investigate main sources of heterogeneity.
We searched MEDLINE, EMBASE, and ISI Web of Science for relevant studies published before May 2015. We used fixed or random effects models and meta-regression to pool the data.
Twenty-five studies were entered into the meta-analysis (90-1,295 patients depending on the analysis). Bleeding was defined as symptomatic hemorrhage plus radiologic evidence of hemorrhage. Sources of heterogeneity were identified as mixture of hemorrhage and rehemorrhage, mixture of rehemorrhage before and after 2 years of first bleeding, brainstem vs other locations, and calculation method. The rehemorrhage rate was higher than the hemorrhage rate (incidence rate ratio 16.5, p < 0.001, 95% confidence interval [CI] 9.7-28.0). Rehemorrhage within 2 years of the first hemorrhage was higher than after that (incidence rate ratio 1.8, p = 0.042, 95% CI 1.5-2.0). In two metaregression models, rough estimate of the annual incidence rate of hemorrhage was 0.3% (95% CI 0.1%-0.5%) and 2.8% (2.5%-3.3%) per person year in nonbrainstem and brainstem lesions and rough estimate of annual rehemorrhage rate per person year was 6.3% (3%-13.2%) and 32.3% (19.8%-52.7%) in nonbrainstem and brainstem lesions. Median time to rehemorrhage was 10.5 months. Posthemorrhage full recovery was 38.8%/person-year (28.7%-48.8%). Posthemorrhage full recovery or minimal disability was 79.5%/person-year (74.3%-84.8%). Mortality after bleeding was 2.2%.
The incidence of symptomatic hemorrhage or rehemorrhage is higher in brainstem lesions. First symptomatic hemorrhage increases the chance of symptomatic rehemorrhage, which decreases after 2 years.
我们汇总了海绵状血管畸形(CM)自然病史的研究结果,以计算点估计值并调查异质性的主要来源。
我们检索了MEDLINE、EMBASE和ISI科学网,查找2015年5月之前发表的相关研究。我们使用固定效应模型或随机效应模型以及meta回归来汇总数据。
25项研究纳入了荟萃分析(根据分析不同,患者数量为90 - 1295例)。出血被定义为有症状性出血加上出血的影像学证据。异质性来源被确定为出血和再出血的混合情况、首次出血2年前后再出血的混合情况、脑干与其他部位、以及计算方法。再出血率高于出血率(发病率比16.5,p < 0.001,95%置信区间[CI] 9.7 - 28.0)。首次出血后2年内的再出血率高于2年后(发病率比1.8,p = 0.042,95% CI 1.5 - 2.0)。在两个meta回归模型中,非脑干和脑干病变患者每年出血发病率的粗略估计分别为0.3%(95% CI 0.1% - 0.5%)和2.8%(2.5% - 3.3%),非脑干和脑干病变患者每年再出血率的粗略估计分别为6.3%(3% - 13.2%)和32.3%(19.8% - 52.7%)。再出血的中位时间为10.5个月。出血后完全恢复率为38.8%/人年(28.7% - 48.8%)。出血后完全恢复或轻度残疾率为79.5%/人年(74.3% - 84.8%)。出血后的死亡率为2.2%。
脑干病变中症状性出血或再出血的发生率更高。首次症状性出血会增加症状性再出血的几率,2年后该几率会降低。